| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.085 | 0.3 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.2 | 0.3 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.24 | 0.3 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.3 |